Research
Hormonal
Semaglutide use is effective in patients with IBD and obesity, resulting in a mean weight loss of over 5%.
Clinicians can consider semaglutide as a viable weight loss option for patients with IBD and obesity.
StrongSupportsmedium confidence
Semaglutide use is effective in patients with IBD and obesity similar to patients without IBD, with >5% mean weight loss.
Why this rating
The study is a retrospective cohort study using a large database.
Source
Effectiveness and Safety of Semaglutide for Weight Loss in Patients With Inflammatory Bowel Disease and Obesity
Aakash Desai et al. · Inflammatory Bowel Diseases · 2024
cohort · n=47424Cited 27×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →